Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 8
• 1.2 List of Figures 13

2 Introduction 14

• 2.1 Peripheral Vascular Stents Overview 14

3 Products under Development 15

• 3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development 15
• 3.2 Peripheral Vascular Stents - Pipeline Products by Segment 16
• 3.3 Peripheral Vascular Stents - Pipeline Products by Territory 17
• 3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path 18
• 3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date 19
• 3.6 Peripheral Vascular Stents - Ongoing Clinical Trials 20

4 Peripheral Vascular Stents - Pipeline Products under Development by Companies 21

• 4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development 21
• 4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development 23

5 Peripheral Vascular Stents Companies and Product Overview 26

• 5.1 3D Biotek LLC Company Overview 26
  • 5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.2 Abbott Vascular Inc Company Overview 27
  • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.3 AlviMedica Medical Technologies Inc Company Overview 31
  • 5.3.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.4 AndraTec GmbH Company Overview 38
  • 5.4.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.5 Arterius Ltd Company Overview 39
  • 5.5.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.6 Boston Scientific Corp Company Overview 40
  • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.7 Cardiatis SA Company Overview 49
  • 5.7.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.8 Cook Medical Inc Company Overview 50
  • 5.8.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.9 Cordis Corp Company Overview 54
  • 5.9.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.10 Corinnova Inc Company Overview 56
  • 5.10.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview 57
  • 5.11.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.12 Efemoral Medical LLC Company Overview 58
  • 5.12.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58
• 5.13 Efferent Labs Inc Company Overview 59
  • 5.13.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59
• 5.14 Electroformed Stents Inc Company Overview 60
  • 5.14.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.15 Elixir Medical Corp Company Overview 63
  • 5.15.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 63
• 5.16 FIT Biotech Oy Company Overview 66
  • 5.16.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 66
• 5.17 ID Nest Medical SAS Company Overview 68
  • 5.17.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 68
• 5.18 InspireMD Inc Company Overview 69
  • 5.18.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 69
• 5.19 Intact Vascular LLC Company Overview 70
  • 5.19.1 Intact Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 70
• 5.20 Kyoto Medical Planning Co Ltd Company Overview 73
  • 5.20.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

6 Peripheral Vascular Stents- Recent Developments 131

• 6.1 Nov 19, 2019: Data show Zilver PTX leads to fewer complications and shorter hospital stays than traditional bypass surgery 131
• 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 131
• 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 133
• 6.4 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 135
• 6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 136
• 6.6 Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer 136
• 6.7 Nov 07, 2019: Neovasc announces third quarter 2019 financial results 137

7 Appendix 283

• 7.1 Methodology 283
• 7.2 About GlobalData 286
• 7.3 Contact Us 286